The effects of chronic morphine on the generalization of buprenorphine stimulus control: An assessment of kappa antagonist activity
- 31 December 1995
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 52 (4) , 779-787
- https://doi.org/10.1016/0091-3057(95)00180-5
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Effects of the benzomorphan κ-opiate, MR 2266 and its (+) enantiomer MR 2267, on thermonociceptive reactions in different strains of miceNeuroscience Letters, 1990
- Animal models of drug withdrawal symptomsPsychopharmacology, 1990
- Centrally administered opioid antagonists, nor-binaltorphimine, 16-methyl cyprenorphine and MR2266, suppress intake of a sweet solutionPharmacology Biochemistry and Behavior, 1990
- Stereospecific effects of a κ-opiate antagonist on the actions of morphine in morphine-tolerant ratsEuropean Journal of Pharmacology, 1989
- Modulation of appetitively and aversively motivated behavior by the kappa opioid antagonist MR2266.Behavioral Neuroscience, 1989
- Naloxone as a stimulus for drug discrimination learningDrug Development Research, 1989
- Kappa receptors mediate the peripheral aversive effects of opiatesPharmacology Biochemistry and Behavior, 1987
- Stereospecific inhibition of oxotremorine-induced antinociception by (+)-isomers of opioid antagonists: comparison with opioid receptor agonistsJournal of Pharmacy and Pharmacology, 1982
- In vivo RECEPTOR BINDING OF THE OPIATE PARTIAL AGONIST, BUPRENORPHINE, CORRELATED WITH ITS AGONISTIC AND ANTAGONISTIC ACTIONSBritish Journal of Pharmacology, 1981
- AGONIST AND ANTAGONIST PROPERTIES OF BUPRENORPHINE, A NEW ANTINOCICEPTIVE AGENTBritish Journal of Pharmacology, 1977